产品中心Product
联系我们Contact Us
联系我们Contact Us
杭州吉沃科技有限公司Hangzhou Geevo Technology Co., Ltd.
地址: Add: 浙江省杭州市余杭经济技术开发区红丰路509号No.509 Hongfeng Road, Yuhang Economic & Technical Development Area, Yuhang District, Hangzhou, Zhejiang, China
电话: Tel: 0571-8993805186 571 89938051
传真: Fax: 0571-8993709386 571 89937093
Q  Q: QQ: 2276956915
邮箱: Email: geevosusan@126.com,
geevotech@126.com
www.geevo.net
扫码访问手机版
Scan it for the mobile version
(wechat scan function)
CP2015与各国药典在无菌检查法上的差异 Gap Assessment and Discussion on Sterility Tests in different Pharmacopoeia
发布时间:2019-02-16     文章浏览:170
Release time:2019-02-16     Times of browsing:170
Gap Assessment and Discussion on Sterility Tests in Chinese Pharmacopeia 2015, United States Pharmacopeia, European Pharmacopeia, and Japanese Pharmacopeia.

Abstract Objective: Gap assessment and discussion on thesterility test methods in Chinese Pharmacopeia 2015 edition (CP2015), United States Pharmacopeia (USP), European Pharmacopeia (EP), and Japanese Pharmacopeia (JP). 
Method: The test procedures and key parameters in the sterility test methods in different pharmacopoeia were compared step by step and the differences were identified. The identified differences are scientifically evaluated for their impact to the equivalence of the methods.
Result: The sterility test method in CP2015 is largely harmonized with that in USP, EP and JP except for a few differences. Positive control and extra incubation bacteria are required in CP2015 only, and Escherichia coli is used in method suitability test in CP2015 while Pseudomonas aeruginosa is used in USP/EP/JP.
Conclusion: The Sterility Test Methods in CP2015, USP, EP, and JP are equivalent. The method in CP2015 could be simplified more without compromising the validity, accuracy and reliability of the method.


Key words: sterility test: Chinese Pharmacopoeia 2015, United States Pharmacopoeia, European Pharmacopoeia, Japanese Pharmacopoeia.

Gap Assessment and Discussion on Sterility Tests in Chinese Pharmacopeia 2015, United States Pharmacopeia, European Pharmacopeia, and Japanese Pharmacopeia.

Abstract Objective: Gap assessment and discussion on thesterility test methods in Chinese Pharmacopeia 2015 edition (CP2015), United States Pharmacopeia (USP), European Pharmacopeia (EP), and Japanese Pharmacopeia (JP). 
Method: The test procedures and key parameters in the sterility test methods in different pharmacopoeia were compared step by step and the differences were identified. The identified differences are scientifically evaluated for their impact to the equivalence of the methods.
Result: The sterility test method in CP2015 is largely harmonized with that in USP, EP and JP except for a few differences. Positive control and extra incubation bacteria are required in CP2015 only, and Escherichia coli is used in method suitability test in CP2015 while Pseudomonas aeruginosa is used in USP/EP/JP.
Conclusion: The Sterility Test Methods in CP2015, USP, EP, and JP are equivalent. The method in CP2015 could be simplified more without compromising the validity, accuracy and reliability of the method.


Key words: sterility test: Chinese Pharmacopoeia 2015, United States Pharmacopoeia, European Pharmacopoeia, Japanese Pharmacopoeia.